Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
NCT ID: NCT00261937
Last Updated: 2013-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
INTERVENTIONAL
2005-12-31
2006-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
NCT02469597
Hypertonic Saline for Acute Bronchiolitis
NCT01247064
Nasal Irrigation in Infants With Bronchiolitis.
NCT02162745
Intravenous Fluids Versus Naso/Orogastric-tube Feeding in Hospitalized Infants With Bronchiolitis
NCT01189149
The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.
NCT00151905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inhaled Furosemide vs Placebo (Normal Saline)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants who are otherwise healthy
* Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
* Parents signed a written informed consent.
Exclusion Criteria
1 Day
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bnai Zion Medical Center
OTHER_GOV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir Kugelman
Role: PRINCIPAL_INVESTIGATOR
Bnai Zion Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bnai Zion Medical Center and Naharia Galilli Medical Center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bar A, Srugo I, Amirav I, Tzverling C, Naftali G, Kugelman A. Inhaled furosemide in hospitalized infants with viral bronchiolitis: a randomized, double-blind, placebo-controlled pilot study. Pediatr Pulmonol. 2008 Mar;43(3):261-7. doi: 10.1002/ppul.20765.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
67/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.